Related Experiment Video
Updated: Sep 21, 2025
09:16
Rapid Fluorescence-based Characterization of Single Extracellular Vesicles in Human Blood with Nanoparticle-tracking Analysis
Published on: January 7, 2019
10.0K
Single extracellular vesicle analysis for early cancer detection
Scott Ferguson1, Katherine S Yang1, Ralph Weissleder2
1Center for Systems Biology, Massachusetts General Hospital, 185 Cambridge St, CPZN 5206, Boston, MA 02114, USA.
Trends in Molecular Medicine
|May 27, 2022
Summary
Extracellular vesicles (EVs) show promise for early cancer detection. Analyzing single EVs (sEVA) using new technologies is crucial for advancing cancer diagnostics and monitoring.
Area of Science:
- Biomedical science
- Oncology
- Molecular biology
Background:
- Extracellular vesicles (EVs) are released by both cancer and host cells into circulation.
- EVs are increasingly recognized for their potential in early cancer detection, disease monitoring, and treatment assessment.
- Tumor characteristics like oncogenes, metabolic rate, pH, and hypoxia influence EV shedding rates.
Purpose of the Study:
- To provide an overview of extracellular vesicles (EVs).
- To explain the rationale for utilizing EVs in early cancer detection.
- To examine emerging single EV analysis (sEVA) technologies and their necessity for early cancer detection.
Main Methods:
- Review of current literature on extracellular vesicles.
- Analysis of factors influencing EV shedding in cancer.
- Examination of novel single EV analysis (sEVA) technologies.
Main Results:
- EVs are shed actively by cancer cells, reflecting tumor characteristics.
- EVs hold significant potential as biomarkers for early cancer detection.
- Emerging sEVA technologies are vital for precise EV characterization.
Conclusions:
- Extracellular vesicles are promising biomarkers for early cancer detection.
- Single EV analysis (sEVA) technologies are essential for advancing cancer diagnostics.
- Further development of sEVA is critical for clinical applications in oncology.
